AP - Merck & Co. Inc., which reports its third-quarter results before the stock markets open Friday, will discuss launch plans for some newly approved drugs — two of which are likely blockbusters — along with a joint venture sale and some executive changes.
Earnings Preview: Merck reports on third quarter (AP)
